000 | 01763 a2200517 4500 | ||
---|---|---|---|
005 | 20250515202331.0 | ||
264 | 0 | _c20100511 | |
008 | 201005s 0 0 eng d | ||
022 | _a1433-2981 | ||
024 | 7 |
_a10.1016/j.clon.2009.11.006 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aWalji, N | |
245 | 0 | 0 |
_aIs there a role for adjuvant hysterectomy after suboptimal concurrent chemoradiation in cervical carcinoma? _h[electronic resource] |
260 |
_bClinical oncology (Royal College of Radiologists (Great Britain)) _cMar 2010 |
||
300 |
_a140-6 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aAged |
650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xtherapeutic use |
650 | 0 | 4 | _aBrachytherapy |
650 | 0 | 4 |
_aCarcinoma, Large Cell _xsecondary |
650 | 0 | 4 |
_aCarcinoma, Squamous Cell _xsecondary |
650 | 0 | 4 | _aChemotherapy, Adjuvant |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aHysterectomy |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aNeoplasm Recurrence, Local _xprevention & control |
650 | 0 | 4 | _aNeoplasm Staging |
650 | 0 | 4 | _aRadiotherapy Dosage |
650 | 0 | 4 | _aRadiotherapy, Adjuvant |
650 | 0 | 4 | _aRetrospective Studies |
650 | 0 | 4 | _aSurvival Rate |
650 | 0 | 4 | _aTime Factors |
650 | 0 | 4 | _aTreatment Outcome |
650 | 0 | 4 |
_aUterine Cervical Neoplasms _xpathology |
700 | 1 | _aChue, A L | |
700 | 1 | _aYap, C | |
700 | 1 | _aRogers, L J | |
700 | 1 | _aEl-Modir, A | |
700 | 1 | _aChan, K K | |
700 | 1 | _aSingh, K | |
700 | 1 | _aFernando, I N | |
773 | 0 |
_tClinical oncology (Royal College of Radiologists (Great Britain)) _gvol. 22 _gno. 2 _gp. 140-6 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.clon.2009.11.006 _zAvailable from publisher's website |
999 |
_c19424877 _d19424877 |